Related Experiment Video
Updated: Jul 11, 2025

Differentiated Mouse Adipocytes in Primary Culture: A Model of Insulin Resistance
Published on: February 17, 2023
Thyroid cancer and insulin resistance
Gabriela Brenta1, Fernando Di Fermo2
1Department of Endocrinology and Metabolism, Unidad Asistencial Dr. César Milstein, Buenos Aires, Argentina. gbrenta@gmail.com.
The study explores the link between diabetes and thyroid cancer, suggesting insulin resistance as a key factor. Metformin may offer benefits, while evidence for GLP-1 receptor agonists is limited.
Area of Science:
- Endocrinology
- Oncology
- Metabolic Diseases
Background:
- A concurrent rise in thyroid cancer and diabetes incidence has been observed.
- Insulin resistance is hypothesized as a potential mediator linking these conditions.
Purpose of the Study:
- To review the association between diabetes and thyroid cancer.
- To investigate the role of insulin resistance in this relationship.
- To explore the impact of antidiabetic agents on thyroid cancer.
Main Methods:
- A narrative review of English-written articles from PubMed and manual searches.
- Inclusion criteria focused on insulin resistance, diabetes, antidiabetic treatments, and thyroid cancer (Jan 2019-Apr 2023).
- Exclusion of preclinical studies, thyroid dysfunction, benign goiter, and obesity-only associations.
Main Results:
- Out of 20 included studies, 8 on insulin resistance/Metabolic Syndrome showed a positive association with thyroid cancer.
- Five studies on diabetes indicated a link with thyroid cancer in four instances.
- Seven studies on antidiabetics suggested potential benefits of metformin, with limited evidence for GLP-1 receptor agonists (GLP-1 RA) and increased thyroid cancer.
Conclusions:
- Observational studies suggest insulin resistance may explain the thyroid cancer-diabetes association, but causality is undetermined.
- Further research is needed on antidiabetic drugs like metformin and GLP-1 RAs regarding their role in thyroid cancer.
- The relationship between antidiabetic agents and thyroid cancer prevalence/progression warrants continued investigation.
More Related Videos
08:47Live Images of GLUT4 Protein Trafficking in Mouse Primary Hypothalamic Neurons Using Deconvolution Microscopy
Published on: December 7, 2017
08:13Study of In Vivo Glucose Metabolism in High-fat Diet-fed Mice Using Oral Glucose Tolerance Test OGTT and Insulin Tolerance Test ITT
Published on: January 7, 2018
Related Concept Videos
Psychoneuroimmunology: Diabetes and Cancer
Carbohydrate Metabolism
Starch accounts for approximately 60% of the carbohydrates consumed by humans. Since amylase enzymes cannot function in the stomach's acidic environment, starch can only be digested in the mouth and small intestine. Simple sugars are found naturally in milk and fruits in...
Oral Hypoglycemic Agents: Biguanides and Glitazones
Diabetes Mellitus: Overview and Type I Subtype
Type 1 diabetes is an autoimmune disease in which the immune system mistakenly attacks and destroys the insulin-producing beta cells in the pancreas. As a result, the body is unable to produce sufficient insulin, and individuals with...
Insulin: The Receptor and Signaling Pathways
Diabetes Mellitus: Type 2 and Gestational